Latest News
- Reader Response: Clinical, Neuroimmunologic, and CSF Investigations in First Episode PsychosisGuasp et al.1 address the central clinical issue of how…
- Author Response: Clinical, Neuroimmunologic, and CSF Investigations in First Episode PsychosisDr. Tebartz et al. misunderstand our manuscript.1 First, since our…
- Patient Selection for Thrombectomy Using Brain Imaging: Does Time Still Matter?Time is brain. For decades, this was the only dogma…
Top 10 rare neurological diseases
Measured by: prevalence
Disease | Est US prevalence | Inheritance | Age of onset |
---|---|---|---|
Narcolepsy | 146,000 – 200,000 | ![]() | ![]() |
Idiopathic hypersomnia | 104,280 – 130,000 | ![]() | ![]() |
Charcot-Marie-Tooth disease | 82,250 – 125,000 | ![]() | ![]() |
Myasthenia-Gravis | 48,000 – 60,000 | ![]() | ![]() |
Young onset parkinson’s disease | 40,000 – 50,000 | ![]() | ![]() |
Lennox-Gastaut syndrome | 30,000 – 45,000 | ![]() | ![]() |
Tuberous sclerosis | 27,000 – 37,500 | ![]() | ![]() |
Huntington disease | 21,450 – 30,000 | ![]() | ![]() |
Progressive supranuclear palsy | 21,000 – 45,870 | ![]() | ![]() |
Amyotrophic lateral sclerosis | 15,000 – 17,500 | ![]() ![]() | ![]() |